Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
Oncology Research · 2026
DOI: 10.32604/or.2026.069012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Adam Khorasanchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Immunotherapy, Immune Checkpoint Inhibitors, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Zitieren
APA
Khorasanchi, A., Hasanov, M., Wu, R., Alsharif, H., Kendra, K., & Verschraegen, C. (2026). Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma. Oncology Research. https://doi.org/10.32604/or.2026.069012
Vancouver
Khorasanchi A, Hasanov M, Wu R, Alsharif H, Kendra K, Verschraegen C. Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma. Oncology Research. 2026. doi:10.32604/or.2026.069012
BibTeX
@article{Khorasanchi2026,
author = {Khorasanchi, Adam and Hasanov, Merve and Wu, Richard and Alsharif, Hisham and Kendra, Kari and Verschraegen, Claire},
title = {Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.069012}
}
EUVIMED